Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Anne M. Gussow

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-56 properties)
Infobox
Patent primary examiner of
‌
US Patent 7812133 Anti-OX40L antibodies and methods using same
‌
US Patent 7829088 Composition comprising humanized antibody HBBK4 for the treatment of cancer and the use thereof
‌
US Patent 7829673 Antibodies against CD38 for treatment of multiple myeloma
‌
US Patent 7829674 Compositions and methods for binding sphingosine-1-phosphate
‌
US Patent 7829678 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
‌
US Patent 7847068 Neutralizing human anti-IGFR antibody
‌
US Patent 7850962 Human monoclonal antibodies against CD20
‌
US Patent 7855276 Framework residue substituted humanized COL-1 antibodies and their use
‌
US Patent 7867734 Anti-glypican 3 antibody having modified sugar chain
‌
US Patent 7871613 Adjuvant therapy with the use of anti-glypican 3 antibody
‌
US Patent 7883853 Diagnosis of hepatocellular carcinoma
‌
US Patent 7893216 Anti-human trail receptor DR5 monoclonal antibody (AD5-10), method thereof and use of the same
‌
US Patent 7897351 Peptides and antibodies to MUC 1 proteins
‌
US Patent 7897730 TRAIL receptor-binding agents and uses of the same
‌
US Patent 7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation
‌
US Patent 7910314 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
‌
US Patent 7910332 Method for manufacturing a recombinant polyclonal protein
‌
US Patent 7910708 Anti-IL13 human antibodies
‌
US Patent 7910711 Human cancer-relating genes, the products encoded thereby and applications thereof
‌
US Patent 7919103 Compound and method for regulating plasminogen activation and cell migration
‌
US Patent 7919594 Human anti-CD100 antibodies
‌
US Patent 7927834 Recombinant production of mixtures of antibodies
‌
US Patent 7931904 Modulation of MUC1 activity
‌
US Patent 7932044 Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-α
‌
US Patent 7935346 Medicament for the two-step perioperative therapy of solid tumours
‌
US Patent 7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology
‌
US Patent 7943744 ICAM-1 binding antibodies
‌
US Patent 7943745 Anti-CD98 antibody
‌
US Patent 7947812 Neoplasm specific antibodies and uses thereof
‌
US Patent 7951369 Chimeric, human and humanized anti-granulocyte antibodies and methods of use
‌
US Patent 7951920 Conjugate of an antibody against CCR5 and an antifusogenic peptide
‌
US Patent 7956173 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate
‌
US Patent 7960517 Methods for antibody engineering
‌
US Patent 7964707 Anti-IL2 antibodies
‌
US Patent 7968316 Method for the mass production of immunoglobulin Fc region deleted initial methionine residues
‌
US Patent 7968514 Pharmaceutical composition for treating or preventing ovarian cancer
‌
US Patent 7968690 Agonist anti-trkC antibodies and methods using same
‌
US Patent 7972870 Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
‌
US Patent 7973135 Compositions and methods for targeting cancer-specific transcription complexes
‌
US Patent 7973136 Optimized anti-CD30 antibodies
‌
US Patent 7977071 Binding moieties based on shark ignar domains
‌
US Patent 7977470 Human Ron-related gene variant associated with cancers
‌
US Patent 7981414 Anti-inflammatory dAb
‌
US Patent 7982012 Compositions and methods for the therapy and diagnosis of cytomegalovirus
‌
US Patent 7982013 Frizzled-binding agents and uses thereof
‌
US Patent 7982017 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
‌
US Patent 7982024 Antibodies to insulin-like growth factor I receptor
‌
US Patent 7989587 SSX-2 peptides presented by HLA class II molecules
‌
US Patent 7989595 Compositions and methods for the diagnosis and treatment of tumor
‌
US Patent 7994290 Effector function enhanced recombinant antibody composition
‌
US Patent 7998689 Detection of CXADR protein for diagnosis of kidney cancer
‌
US Patent 7999071 Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1
‌
US Patent 8007796 Means and methods for the treatment of tumorous diseases
‌
US Patent 8008256 Combination therapy for treatment of cancer
‌
US Patent 8008266 Methods of treating cancer using immunostimulatory oligonucleotides
‌
US Patent 8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer
Edits on 13 Dec, 2021
Golden AI profile picture
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8008266 Methods of treating cancer using immunostimulatory oligonucleotides
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8008256 Combination therapy for treatment of cancer
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8007796 Means and methods for the treatment of tumorous diseases
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7998689 Detection of CXADR protein for diagnosis of kidney cancer
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7994290 Effector function enhanced recombinant antibody composition
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7989595 Compositions and methods for the diagnosis and treatment of tumor
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7989587 SSX-2 peptides presented by HLA class II molecules
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7982024 Antibodies to insulin-like growth factor I receptor
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7982012 Compositions and methods for the therapy and diagnosis of cytomegalovirus
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7982013 Frizzled-binding agents and uses thereof
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7981414 Anti-inflammatory dAb
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7977470 Human Ron-related gene variant associated with cancers
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7977071 Binding moieties based on shark ignar domains
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7973136 Optimized anti-CD30 antibodies
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7973135 Compositions and methods for targeting cancer-specific transcription complexes
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7972870 Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3

Find more people like Anne M. Gussow

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo